Advisors Asset Management, Inc. Ligand Pharmaceuticals Inc Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $3,406 - $3,887	-49 Reduced 0.69%	7,051 $508,000
Q1 2023 May 12, 2023	SELL	$65.67 - $77.08 $7,486 - $8,787	-114 Reduced 1.58%	7,100 $522,000
Q4 2022 Feb 13, 2023	SELL	$61.72 - $96.74 $19,380 - $30,376	-314 Reduced 4.17%	7,214 $481,000
Q3 2022 Nov 08, 2022	SELL	$0.01 - $107.56 $3 - $40,980	-381 Reduced 4.82%	7,528 $648,000
Q2 2022 Aug 08, 2022	SELL	$74.52 - $117.06 $385,044 - $604,849	-5,167 Reduced 39.52%	7,909 $706,000
Q1 2022 May 17, 2022	BUY	$94.99 - $151.56 $383,854 - $612,453	4,041 Added 44.73%	13,076 $1.47 Million
Q4 2021 Feb 15, 2022	BUY	$127.69 - $165.85 $250,910 - $325,895	1,965 Added 27.79%	9,035 $1.4 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $10,028 - $14,183	-98 Reduced 1.37%	7,070 $985,000
Q2 2021 Jul 30, 2021	SELL	$113.03 - $155.64 $3,277 - $4,513	-29 Reduced 0.4%	7,168 $940,000
Q1 2021 May 07, 2021	SELL	$99.52 - $215.83 $14,430 - $31,295	-145 Reduced 1.97%	7,197 $1.1 Million
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $119,133 - $156,847	1,479 Added 25.23%	7,342 $730,000
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $176,970 - $250,398	1,976 Added 50.84%	5,863 $559,000
Q2 2020 Aug 12, 2020	BUY	$68.28 - $123.65 $29,770 - $53,911	436 Added 12.63%	3,887 $435,000
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $126,549 - $215,436	-1,997 Reduced 36.66%	3,451 $251,000
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $83,465 - $97,800	-861 Reduced 13.65%	5,448 $568,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $237,618 - $331,040	-2,755 Reduced 30.39%	6,309 $628,000
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $33,395 - $40,224	-311 Reduced 3.32%	9,064 $1.04 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $18,749 - $25,217	-177 Reduced 1.85%	9,375 $1.18 Million
Q4 2018 Jan 31, 2019	BUY	$128.36 - $272.13 $121,556 - $257,707	947 Added 11.01%	9,552 $1.3 Million
Q3 2018 Nov 15, 2018	BUY	$211.18 - $274.49 $465,229 - $604,701	2,203 Added 34.41%	8,605 $2.36 Million
Q2 2018 Aug 22, 2018	BUY	$150.77 - $207.98 $897,835 - $1.24 Million	5,955 Added 1332.21%	6,402 $1.33 Million
Q2 2018 Aug 15, 2018	SELL	$150.77 - $207.98 $487,288 - $672,191	-3,232 Reduced 87.85%	447 $1.33 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $36,875 - $48,576	266 Added 7.79%	3,679 $559,000
Q4 2017 Feb 13, 2018	BUY	$128.36 - $147.04 $129,515 - $148,363	1,009 Added 41.97%	3,413 $467,000
Q3 2017 Nov 07, 2017	BUY	$120.91 - $137.94 $290,667 - $331,607	2,404	2,404 $327,000

Others Institutions Holding LGND

# of Institutions

249

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

Black Rock Inc. New York, NY

2.87M
Shares

$326 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.93M
Shares

$218 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

1.01M
Shares

$114 Million
0.05% of portfolio
Macquarie Group LTD Australia, C3

967K
Shares

$110 Million
0.1% of portfolio
Dimensional Fund Advisors LP Austin, TX

709K
Shares

$80.3 Million
0.02% of portfolio

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account